52 related articles for article (PubMed ID: 9160787)
1. Nitric oxide and oxidative stress pathways do not contribute to sex differences in renal injury and function in Dahl SS/Jr rats.
Turbeville HR; Johnson AC; Garrett MR; Dent EL; Sasser JM
Physiol Rep; 2020 Jul; 8(13):e14440. PubMed ID: 32652814
[TBL] [Abstract][Full Text] [Related]
2. A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.
Katori M; Majima M
Pharmaceuticals (Basel); 2010 Jan; 3(1):59-109. PubMed ID: 27713243
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum for: Nitric Oxide and Salt Resistance in Dahl Rats: No Role of Inducible NO Synthase.
Zicha J; Řezáčová L; Vaněčková I
Physiol Res; 2023 Nov; 72(5):682. PubMed ID: 38015767
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1.
Maneva-Radicheva L; Amatya C; Parker C; Ellefson J; Radichev I; Raghavan A; Charles ML; Williams MS; Robbins MS; Savinov AY
PLoS One; 2014; 9(9):e107213. PubMed ID: 25259810
[TBL] [Abstract][Full Text] [Related]
5. Blood pressures, heart rate and locomotor activity during salt loading and angiotensin II infusion in protease-activated receptor 2 (PAR2) knockout mice.
McGuire JJ; Van Vliet BN; Halfyard SJ
BMC Physiol; 2008 Oct; 8():20. PubMed ID: 18939990
[TBL] [Abstract][Full Text] [Related]
6. Association of the human bradykinin B2 receptor gene with chronic renal failure.
Jozwiak L; Drop A; Buraczynska K; Ksiazek P; Mierzicki P; Buraczynska M
Mol Diagn; 2004; 8(3):157-61. PubMed ID: 15771553
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
Shimamoto K; Matsuki T; Iimura O
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S83-90. PubMed ID: 1697368
[TBL] [Abstract][Full Text] [Related]
8. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats.
Uehara Y; Hirawa N; Kawabata Y; Suzuki T; Ohshima N; Oka K; Ikeda T; Goto A; Toyo-oka T; Kizuki K
Hypertension; 1994 Dec; 24(6):770-8. PubMed ID: 7995636
[TBL] [Abstract][Full Text] [Related]
9. Regression of glomerular injury by kallikrein infusion in Dahl salt-sensitive rats is a bradykinin B2-receptor-mediated event.
Hirawa N; Uehara Y; Suzuki T; Kawabata Y; Numabe A; Gomi T; lkeda T; Kizuki K; Omata M
Nephron; 1999 Feb; 81(2):183-93. PubMed ID: 9933754
[TBL] [Abstract][Full Text] [Related]
10. The implication of renin-angiotensin system on renal injury seen in Dahl salt-sensitive rats.
Hirawa N; Uehara Y; Numabe A; Kawabata Y; Gomi T; Ikeda T; Ohnishi T; Ishii M; Omata M
Am J Hypertens; 1997 May; 10(5 Pt 2):102S-106S. PubMed ID: 9160791
[TBL] [Abstract][Full Text] [Related]
11. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats.
Ideishi M; Miura S; Sakai T; Sasaguri M; Misumi Y; Arakawa K
J Hypertens; 1994 Jun; 12(6):653-61. PubMed ID: 7963490
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats.
Hirawa N; Uehara Y; Kawabata Y; Ohshima N; Ono H; Nagata T; Gomi T; Ikeda T; Goto A; Yagi S
J Hypertens; 1994 Aug; 12(8):909-18. PubMed ID: 7814850
[TBL] [Abstract][Full Text] [Related]
13. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats.
Uehara Y; Hirawa N; Numabe A; Kawabata Y; Ikeda T; Gomi T; Gotoh A; Omata M
Am J Hypertens; 1997 May; 10(5 Pt 2):83S-88S. PubMed ID: 9160787
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
